Codexis Buys BioCatalytics

Codexis Inc., a Redwood City, Calif.-based provider of solutions for pharma chemical process development and manufacturing, has acquired BioCatalytics Inc., a Pasadena, Calif.-based maker of off-the-shelf enzymes used in chemical process manufacturing by pharma and fine chemical companies. Codexis has raised $75 million in VC funding since 2002, from firms like CCTV Investments, CMEA Ventures, Pequot Capital, Bio*One Capital and Pfizer.